SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-03-031820
Filing Date
2003-08-08
Accepted
2003-08-08 15:12:48
Documents
8
Period of Report
2003-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR PERIOD ENDED JUNE 30, 2003 d10q.htm 10-Q 511208
3 INDENTURE BY AND BETWEEN DURECT CORPORATION AND THE BANK OF NEW YORK dex44.htm EX-4.4 484531
4 REGISTRATION RIGHT AGREEMENT dex45.htm EX-4.5 106252
5 CONVERTIBLE NOTE PURCHASE AGREEMENT dex1035.htm EX-10.35 103970
6 CEO CERTIFICATION FILED PURSUANT TO SECTION 302 dex311.htm EX-31.1 9953
7 CFO CERTIFICATION FILED PURSUANT TO SECTION 302 dex312.htm EX-31.2 9946
8 CEO CERTIFICATION FILED PURSUANT TO SECTION 906 dex321.htm EX-32.1 3218
9 CFO CERTIFICATION FILED PURSUANT TO SECTION 906 dex322.htm EX-32.2 3209
  Complete submission text file 0001193125-03-031820.txt   1234764
Mailing Address 10240 BUBB ROAD CUPERTINO CA 95014
Business Address 10240 BUBB RD CUPERTINO CA 95014 4087771417
DURECT CORP (Filer) CIK: 0001082038 (see all company filings)

IRS No.: 943297098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31615 | Film No.: 03831609
SIC: 2834 Pharmaceutical Preparations